-
Je něco špatně v tomto záznamu ?
Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases
PM. Seferović, WJ. Paulus, G. Rosano, M. Polovina, MC. Petrie, PS. Jhund, C. Tschöpe, N. Sattar, M. Piepoli, Z. Papp, E. Standl, MA. Mamas, P. Valensi, A. Linhart, N. Lalić, A. Ceriello, W. Döhner, A. Ristić, I. Milinković, J. Seferović, F....
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu konsensus - konference, časopisecké články
NLK
Medline Complete (EBSCOhost)
od 2000-03-01 do Před 1 rokem
Wiley Free Content
od 1999 do Před 1 rokem
PubMed
38896048
DOI
10.1002/ejhf.3347
Knihovny.cz E-zdroje
- MeSH
- diabetes mellitus 2. typu * komplikace MeSH
- diabetická kardiomyopatie * diagnóza patofyziologie MeSH
- lidé MeSH
- společnosti lékařské MeSH
- srdeční selhání * diagnóza etiologie patofyziologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- konsensus - konference MeSH
The association between type 2 diabetes mellitus (T2DM) and heart failure (HF) has been firmly established; however, the entity of diabetic myocardial disorder (previously called diabetic cardiomyopathy) remains a matter of debate. Diabetic myocardial disorder was originally described as the occurrence of myocardial structural/functional abnormalities associated with T2DM in the absence of coronary heart disease, hypertension and/or obesity. However, supporting evidence has been derived from experimental and small clinical studies. Only a minority of T2DM patients are recognized as having this condition in the absence of contributing factors, thereby limiting its clinical utility. Therefore, this concept is increasingly being viewed along the evolving HF trajectory, where patients with T2DM and asymptomatic structural/functional cardiac abnormalities could be considered as having pre-HF. The importance of recognizing this stage has gained interest due to the potential for current treatments to halt or delay the progression to overt HF in some patients. This document is an expert consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases. It summarizes contemporary understanding of the association between T2DM and HF and discuses current knowledge and uncertainties about diabetic myocardial disorder that deserve future research. It also proposes a new definition, whereby diabetic myocardial disorder is defined as systolic and/or diastolic myocardial dysfunction in the presence of diabetes. Diabetes is rarely exclusively responsible for myocardial dysfunction, but usually acts in association with obesity, arterial hypertension, chronic kidney disease and/or coronary artery disease, causing additive myocardial impairment.
Amsterdam University Medical Centers Amsterdam The Netherlands
Cardiology San Raffaele Cassino Hospital Cassino Italy
Cardiology University Department RCCS Policlinico San Donato San Donato Milanese Italy
Cardiovascular Research Group Keele University Keele UK
Center for Stroke Research Berlin Charité Universitätsmedizin Berlin Berlin Germany
Department of Biomedical Sciences for Health University of Milan Milan Italy
Department of Cardiology University Clinical Centre of Serbia Belgrade Serbia
Department of Endocrinology University Clinical Centre of Serbia Belgrade Serbia
Diabetes Research Group e 5 at Munich Helmholtz Center Munich Germany
Faculty of Medicine University of Belgrade Belgrade Serbia
Heart Research Institute Sydney NSW Australia
Polyclinique d'Aubervilliers Aubervilliers and Paris Nord University Bobigny France
School of Cardiovascular and Metabolic Health University of Glasgow Glasgow UK
Serbian Academy of Sciences and Arts Belgrade Serbia
Unit of Cardiology Karolinska Institute and Karolinska University Hospital Stockholm Sweden
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25004133
- 003
- CZ-PrNML
- 005
- 20250206105944.0
- 007
- ta
- 008
- 250121s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/ejhf.3347 $2 doi
- 035 __
- $a (PubMed)38896048
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Seferović, Petar M $u Faculty of Medicine, University of Belgrade, Belgrade, Serbia $u Serbian Academy of Sciences and Arts, Belgrade, Serbia $1 https://orcid.org/0000000219554199
- 245 10
- $a Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases / $c PM. Seferović, WJ. Paulus, G. Rosano, M. Polovina, MC. Petrie, PS. Jhund, C. Tschöpe, N. Sattar, M. Piepoli, Z. Papp, E. Standl, MA. Mamas, P. Valensi, A. Linhart, N. Lalić, A. Ceriello, W. Döhner, A. Ristić, I. Milinković, J. Seferović, F. Cosentino, M. Metra, AJS. Coats
- 520 9_
- $a The association between type 2 diabetes mellitus (T2DM) and heart failure (HF) has been firmly established; however, the entity of diabetic myocardial disorder (previously called diabetic cardiomyopathy) remains a matter of debate. Diabetic myocardial disorder was originally described as the occurrence of myocardial structural/functional abnormalities associated with T2DM in the absence of coronary heart disease, hypertension and/or obesity. However, supporting evidence has been derived from experimental and small clinical studies. Only a minority of T2DM patients are recognized as having this condition in the absence of contributing factors, thereby limiting its clinical utility. Therefore, this concept is increasingly being viewed along the evolving HF trajectory, where patients with T2DM and asymptomatic structural/functional cardiac abnormalities could be considered as having pre-HF. The importance of recognizing this stage has gained interest due to the potential for current treatments to halt or delay the progression to overt HF in some patients. This document is an expert consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases. It summarizes contemporary understanding of the association between T2DM and HF and discuses current knowledge and uncertainties about diabetic myocardial disorder that deserve future research. It also proposes a new definition, whereby diabetic myocardial disorder is defined as systolic and/or diastolic myocardial dysfunction in the presence of diabetes. Diabetes is rarely exclusively responsible for myocardial dysfunction, but usually acts in association with obesity, arterial hypertension, chronic kidney disease and/or coronary artery disease, causing additive myocardial impairment.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a diabetes mellitus 2. typu $x komplikace $7 D003924
- 650 12
- $a diabetická kardiomyopatie $x diagnóza $x patofyziologie $7 D058065
- 650 12
- $a srdeční selhání $x diagnóza $x etiologie $x patofyziologie $7 D006333
- 650 _2
- $a společnosti lékařské $7 D012955
- 655 _2
- $a konsensus - konference $7 D016446
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Paulus, Walter J $u Amsterdam University Medical Centers, Amsterdam, The Netherlands
- 700 1_
- $a Rosano, Giuseppe $u Department of Human Sciences and Promotion of Quality of Life, San Raffaele Open University of Rome, Rome, Italy $u Cardiology, San Raffaele Cassino Hospital, Cassino, Italy
- 700 1_
- $a Polovina, Marija $u Faculty of Medicine, University of Belgrade, Belgrade, Serbia $u Department of Cardiology, University Clinical Centre of Serbia, Belgrade, Serbia
- 700 1_
- $a Petrie, Mark C $u School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK
- 700 1_
- $a Jhund, Pardeep S $u School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK
- 700 1_
- $a Tschöpe, Carsten $u Berlin Institute of Health at Charité - Center for Regenerative Therapies, Universitätsmedizin Berlin, Berlin, Germany $u Deutsches Herzzentrum der Charité, Department of Cardiology (CVK) and German Centre for Cardiovascular Research (DZHK)- Partner Site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany
- 700 1_
- $a Sattar, Naveed $u School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK
- 700 1_
- $a Piepoli, Massimo $u Cardiology University Department, RCCS Policlinico San Donato, San Donato Milanese, Italy $u Department of Biomedical Sciences for Health, University of Milan, Milan, Italy
- 700 1_
- $a Papp, Zoltán $u Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
- 700 1_
- $a Standl, Eberhard $u Diabetes Research Group e.V. at Munich Helmholtz Center, Munich, Germany
- 700 1_
- $a Mamas, Mamas A $u Cardiovascular Research Group, Keele University, Keele, UK
- 700 1_
- $a Valensi, Paul $u Polyclinique d'Aubervilliers, Aubervilliers, and Paris Nord University, Bobigny, France
- 700 1_
- $a Linhart, Ales $u Department of Internal Medicine, School of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Lalić, Nebojša $u Faculty of Medicine, University of Belgrade, Belgrade, Serbia $u Serbian Academy of Sciences and Arts, Belgrade, Serbia $u Department of Endocrinology, University Clinical Centre of Serbia, Belgrade, Serbia
- 700 1_
- $a Ceriello, Antonio $u IRCCS MultiMedica, Milan, Italy
- 700 1_
- $a Döhner, Wolfram $u Berlin Institute of Health at Charité - Center for Regenerative Therapies, Universitätsmedizin Berlin, Berlin, Germany $u Deutsches Herzzentrum der Charité, Department of Cardiology (CVK) and German Centre for Cardiovascular Research (DZHK)- Partner Site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany $u Center for Stroke Research Berlin (CSB), Charité Universitätsmedizin Berlin, Berlin, Germany
- 700 1_
- $a Ristić, Arsen $u Faculty of Medicine, University of Belgrade, Belgrade, Serbia $u Department of Cardiology, University Clinical Centre of Serbia, Belgrade, Serbia
- 700 1_
- $a Milinković, Ivan $u Faculty of Medicine, University of Belgrade, Belgrade, Serbia $u Department of Cardiology, University Clinical Centre of Serbia, Belgrade, Serbia
- 700 1_
- $a Seferović, Jelena $u Faculty of Medicine, University of Belgrade, Belgrade, Serbia $u Department of Endocrinology, University Clinical Centre of Serbia, Belgrade, Serbia
- 700 1_
- $a Cosentino, Francesco $u Unit of Cardiology, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden
- 700 1_
- $a Metra, Marco $u Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy
- 700 1_
- $a Coats, Andrew J S $u Heart Research Institute, Sydney, NSW, Australia
- 773 0_
- $w MED00006634 $t European journal of heart failure $x 1879-0844 $g Roč. 26, č. 9 (2024), s. 1893-1903
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38896048 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206105940 $b ABA008
- 999 __
- $a ok $b bmc $g 2263716 $s 1240140
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 26 $c 9 $d 1893-1903 $e 20240619 $i 1879-0844 $m European journal of heart failure $n Eur J Heart Fail $x MED00006634
- LZP __
- $a Pubmed-20250121
